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PP-013 Occurrence of AmpC beta-lactamases among MDR
gram negative urinary tract isolates in Nepal
Bharat Mani Pokherel1, Bal Krishna Awal1, Janak Lal Pathak*,2.
1Department of Clinical Microbiology, Tribhuvan University
Teaching Hospital (TUTH), Kathmandu, Nepal; 2Department of
Clinical Laboratory Medicine, Union Hospital, Huazhong
University of Science and Technology, Hubei, Wuhan, China
Objectives: AmpC beta-lactamases are clinically important
cephalosporinases that confer resistance to wide variety of
beta-lactam drugs, which result in considerable treatment fail-
ure and cannot be detected by routine antibiotic sensitivity
screening methods. Research was designed to estimate emer-
gence of AmpC beta-lactamase (AmpC) producing strains among
multi-drug resistant (MDR) urinary tract isolates in Nepal.
Methods: 2837 urine samples were obtained for culture from
clinically suspected urinary tract infection (UTI) patients from
July, 2005 to March, 2007. Isolates were tested to detect antibi-
otic susceptibility. MDR gram negative isolates were screened for
AmpC producers by modiﬁed double disk approximation method
(MDMM) and conﬁrmed by three dimensional extract method
as described by American Society for Microbiology (ASM) and
National Committee for Clinical Laboratory Standard (NCCLS).
Results: Among 2837 urine samples, 31.4% (891/2837) had signiﬁ-
cant bacterial growth with 825 (92.6%) non-repeat gram-negative
isolates. Out of gram-negative isolates 67.1% (554/825) were
MDR. 5.41% (30/554) of MDR were AmpC positive. Among Indi-
vidual MDR isolates species, 6.1% E. coli, 8.33% Klebsiella, 3.12%
Pseudomonas and 4.0% Proteus were AmpC producing.
Conclusion: These data conﬁrm that AmpC is emerging cause of
MDR in Nepal. We need to subject these strains for genetic study
to acquire genetic make up. Failure to detect AmpC can con-
tribute their uncontrolled nosocomial transmission, therapeutic
failures and increased cost of management. Our results suggest
to start screening of AmpC among MDR gram negative isolates
in routine hospital practices in order to guide the choice of
empirical therapy for such infections.
PP-014 Phytochemical and antibacterial studies on the
seed coat of Detarium microcarpum Guill and
Sperr
Godwin C. Ebi 1, Ozadheoghene E. Aﬁeroho*,2. 1Department of
Pharmaceutical and Medicinal Chemistry, University of Nigeria,
Nsukka, Nigeria; 2Department of Medicinal Chemistry and
Quality Control, National Institute for Pharmaceutical Research
and Development, Abuja, Nigeria
Objectives: To investigate the antibacterial and phytochemical
properties of the seeds coat of Detarium microcarpum.
Methods: Extraction was by exhaustive cold maceration in 90%
aqueous methanol. Silica gel 60G TLC separation done with
Butan-2-one: chloroform: acetic acid: water (40:40:2:1v/v) as
mobile phase. Bands were visualised in daylight and UV light.
Band B1 was further puriﬁed by precipitating with acetone
to obtain the acetone soluble AS and insoluble AP isolates.
Phytochemistry was by using standard phytochemical screening
reagents, and UV spectroscopy. Antibacterial screening was by
the agar diffusion method.
Results: On TLC, the ES fraction gave eight constituents B1
(Rf=0.000), B2 (Rf=0.079), B3 (Rf=0.250), B4 (Rf=0.286), B5
(Rf=0.500), B6 (Rf=0.686), B7 (Rf=0.814), and B8 (Rf=1.000). B1
retained the antibacterial activity spectrum, B2 and B3 showed
residual inhibition against B. subtilis, B4-B8 were inactive. The
AS isolate form B1 exhibited a higher activity than the AP iso-
late. From phytochemistry, B1 contained steroidal saponins and
ﬂavonoid, AP steroidal saponins, AS, B2 and B3 are ﬂavonoids.
B2 and B3 revealed the characteristic benzopyrone maxima
(236nm-300nm). Against the selected bacteria, MIC range of
0.9053-3.5801mg/ml was observed.
Conclusion: This study revealed the antibacterial principles in
the seed coat of D. microcarpum to be steroidal saponins and
ﬂavonoids with synergistic possibilities, and the lead optimisation
potentials of phytoalexins in the seed coats of edible legumes.
Acknowledgement: The in vitro antimicrobial studies assistance
of Mr Okposo of the University’s Pharmaceutics Department.
PP-015 Sika deer as a new source of human infection by
brucella
Guofeng Li, Runping Gao*, Ruijuan Zhang, Yongguang Yang.
Dept. of Infectious Diseases, First Hospital Jilin University
Background: The prevalence of brucellosis is increasing in China
over the past several years. The purpose of this study was to
investigate whether the sika deer serves as a source of human
infection by brucella in Jilin Province of Northeast China.
Methods: Brucellosis was diagnosed in 57 patients during the
periods from June 2007 through December 2008 in our hospital.
The sources of infection and routes of transmission were investi-
gated. Blood samples from these patients and 6 sika deer were
obtained for Brucella antibody testing and culturing bacteria.
Results: Of the 57 patients, 3 (1 man and 2 women) were sika
deer breeders. They were from two families, and each family
has a herd of approximately 60 sika deer. They observed several
abortions in their deer before they were sick. All 3 patients had
prolonged intermittent fevers, night sweats, body aches, arthral-
gias, and weakness. Blood samples from these patients were
negative for brucella culture, but positive for brucella antibodies
in the agglutination test. In the 6 relevant sika deer (3 males and
3 females) examined, 1 presented with orchitis, 1 had right knee
arthritis, and 1 showed progress body weight loss. However, all 6
sika deer were positive for brucella antibodies as determined by
an agglutination test, and 1 of them was also positive for brucella
bovis in the blood culture.
Conclusion: Sika deer can be infected with Brucella bovis, and
serve as a bacteria reservoir and transmit the infection to human
in Northeast China.
PP-016 Molecular epidemiology of Pseudomonas
aeruginosa in a burn unit, Tehran
Parviz Owlia*,1, Hassan Salimi 2, Bagher Yakhchali 2, Abdolaziz
Rastegar Lari 3. 1Dept. of Microbiology, Faculty of Medicine,
Shahed University, Tehran, Iran; 2National Institute of Genetic
Engineering and Biotechnology, Tehran, Iran; 3Antimicrobial
Resistance Research Group, Iran University of Medical Sciences,
Tehran, Iran
Background: The burn wound represents a site susceptible
to colonization of opportunistic pathogens, e.g. Pseudomonas
aeruginosa. This study was planning to investigate drug suscepti-
bility and routes of transmission by molecular epidemiology in P.
aeruginosa isolated in a Burn unit.
Methods: To study the drug susceptibility and molecular epi-
demiology of P. aeruginosa colonization in the burn unit of Shahid
Motahhari Hospital (Tehran), 127 clinical and 2 environmental
P. aeruginosa isolates were collected during 6 months. All P.
aeruginosa isolates were analyzed for drug susceptibility by disk
diffusion method and molecular epidemiology assessment were
done by random ampliﬁed polymorphic DNA (RAPD) analysis.
Results: Drug susceptibility tests were shown high resistance for
ceftizoxime (86.8%), aztreonam (80.6%), kanamycin (79.8%),
tetracycline (78.3%), and ceftazidime (75.2%), furthermore,
high susceptibility for some antibiotics like imipenem (69.8%),
piperacillin/tazobactam (65.9%), and amikacin (58.9%) was
showed. In this study, 42 multidrug-resistant (MDR) P. aerugi-
nosa isolates were recovered from clinical specimens and also,
one isolate was recovered from environment. Molecular typing
revealed eight different proﬁles that include two proﬁles, RAPD1
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and RAPD4, with environmental resource. The major RAPD proﬁle
was RAPD1 proﬁle (n=64, 50.4%), which includes 31 (72.1%) MDR
isolates with one environmental reservoir. In summery we found
three different proﬁles for MDR strains. Different RAPD proﬁles
suggested the different exogenous or endogenous sources of
infection.
Conclusion: Our ﬁndings highlighted the need for further at-
tention to disinfection inanimate hospital environment to limit
transfer of P. aeruginosa in this BU; moreover, use of some
antimicrobial agents must be restricted.
PP-017 The primary investigation of catheter-related
infection in severe patients of emergency
intensive care unit of Ruijin Hospital
Zai-Qian Che*, Yi-Jun Yang, Zhi-Tao Yang, Feng Jing,
Er-Zhen Chen. Emergency Intensive Care Unit, Ruijin Hospital,
Shanghai, China
Background: Infection control is of key importance especially in
critically ill patients. We investigated catheter-related infections
retrospectively in severe patients in Emergency intensive care
unit (EICU) in our hospital in order to adopt effective measures
to decrease mortality in severe patients.
Methods: The patient’s data (from May, 2008 to January,
2009) were collected retrospectively, including ICU stay, day of
catheterization (central line, urinary catheter, artiﬁcial airway),
number of catheter infection and catheter-related bloodstream
infection, number of catheter-related urinary system infection,
number of hospital-acquired pneumonia (HAP) and ventilator-
associated pneumonia (VAP), and microbiological culture results
of sputum at different stages, respectively. Catheter -associated
infection rate (per 1000 device-days) was calculated according to
the National Nosocomial Infections Surveillance (NNIS) System.
Results: A total number of 153 severe patients were enrolled in
the study and the total hospitalization day was 3023. Catheter
-associated infection rate (per 1000 device-days) was 6.89 for
central catheter, 8.91 for urinary catheter and 33.11 for artiﬁcial
airway. The incidence rate of HAP is 21.57%, of which 44.12%
was VAP. 84.62% of patients received mechanical ventilation
more than 7 days presents VAP. The main pathogens of HAP
were gram negative bacteria, 81.64% (80/98), followed by gram
positive bacteria, 81.64% (18/98), which was mainly composed
of MRSA(+) bacteria (77.78%). Non-fermentation gram negative
bacilli (NFGNB) were the major component of gram negative
bacteria (67.5%).
Conclusion: Our rates of catheter-associated infection (per 1000
device-days) are higher than the corresponding NNIS rates in
2008.
PP-018 Botryomycosis as a umbilical nodule, as a
diferential diagnosis for umbilical hernia
Guilherme Peterson*, Tomaz Grezzana. Hospital de Clinicas de
Porto Alegre
Case Description: A 54 year old obese woman presented with
chronic periumbilical pain. An ultrasound showed a nodule in
the umbilicus, presumably an umbilical hernia. During surgery an
abscess in the aponeurosis, under the umbilicum was identiﬁed.
Transoperatory frozen section examination showed no cellular
displasia. Deﬁnitive anatomopathological examination showed
bacterial and ﬁbrous tissue, consistent with botryomycosis. Gram
positive cocci strains and gram negative baccilus were isolated
from the secretion, no bacteria growth was identiﬁed in cultures.
Revision of literature: Botryomycosis is a rare bacterial chronic
infection, mostly seen in skin and cutaneous tissue, but also
described in lung, liver, spleen and other viscera. It is more
frequently associated to imunossupressed individuals, such as
AIDS, alcoholism and diabetes mellitus.
Few cases of botryomycosis of the abdominal wall were de-
scribed, and mostly were related to uterine devices, in such case
Actinomyces were isolated.
PP-019 In vitro activity of tigecycline against
panresistant Klebsiella pneumoniae clinical
isolates
Asimoula Koteli *,1, Savvato Tsingene1, Eleftheria Chasou2,
Georgios Voloudakis 3, Eleni Antoniadou2. 1Microbiology
Laboratory, “G. Genimmatas” General Hospital of Thessaloniki;
2Intensive Care Unit, “G. Genimmatas” General Hospital of
Thessaloniki; 3Medical School, University of Crete, Heraklion
Objectives: to evaluate the in vitro activity of tigecycline against
panresistant K. pneumoniae clinical isolates from ICU patients
with nosocomial infection.
Methods: We examined 13 non duplicated panresistant K. pneu-
moniae isolates recovered 10 from blood cultures, 1 from urine
sample, 1 from nose and 1from bed derived from ICU-patients
during June 2008 to February 2009. The identiﬁcation of the iso-
lates and the susceptibility testing were performed by the VITEK
2 system (bioMerieux®, France). The susceptibility testing for
tigecycline was performed by Kirby-Bauer disk diffusion method.
Paper disks containing tigecycline at 15 μg per disk were used
(Oxoid Ltd, England). The determination of tigecycline MICs val-
ues was performed by E-test strips (AB-Biodisk, Sweden). Isolates
with an inhibition zone diameter of ≥19 mm and with an MIC
level ≤1 μg/mL were considered as susceptible to tigecycline
(MIC susceptibility limits determined by EUCAST). All isolates
were screened for MBL production and for extended-spectrum
β-lactamase. K. pneumoniae ATCC 70603 was used as a positive
ESBLs strain.
Results: All the K. pneumoniae clinical isolates were resistant to
b-lactams, aminoglycosides, carbapenems, monobactames, ce-
falosporines, furanes, cinolones and colistin.The phenotypic test
for ESBL-production was positive in all isolates that were identi-
ﬁed as possible KPC-producers. The tigecycline was found abso-
lute active to all the examined isolates. The inhibition diameter
zones were found of ≥21 mm and the MIC levels of <0.5 μg/mL.
Conclusion: Tigecycline is absolute active to panresistant
K. pneumoniae isolates. Tigecycline presented consistently low
MIC90 values and broad spectrum of activity, including otherwise
resistant strains.
PP-020 A comparative study of therapeutic effects of
Zataria Multiﬂora vaginal cream and
metronidazole vaginal gel on bacterial vaginosis
Masoumeh Simbar*,1, Zohreh Azarbad2. 1Shahid Beheshti
Medical Science University; 2Kashan Medical Science University
Introduction: Bacterial vaginosis (BV) is one of most prevalent
complications among reproductive aged women. Metromidazole
prescription which is considered as the ﬁrst line treatment of BV
